skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines ImlunestrantQuestion & answer

Imlunestrant · Medicine question

Why is imlunestrant under additional monitoring?

iatroX medicinesPublished 17 August 2026Reviewed 17 August 2026

The answer

Answer

It is newly authorised, so suspected adverse reactions are monitored particularly closely and can be reported through the Yellow Card Scheme.

Sources for this answer

Inluriyo 200 mg film-coated tabletsemc · SmPC Current selected SmPC · Version 1
UK GovernmentUK Government · Reputable Web

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

Imlunestrant

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the Imlunestrant guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX

More questions about Imlunestrant

What type of breast cancer is imlunestrant licensed to treat?Why is ESR1 testing needed?Is imlunestrant chemotherapy?Can imlunestrant be taken with food?Can the tablets be crushed or split?Does imlunestrant affect liver blood tests?